| Glioma Diagnosis and Treatment | Lifetime | 45 | US 33 | 99.80 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 23 | US 18 | 99.54 |
| Meningioma and schwannoma management | Lifetime | 61 | US 41 | 99.52 |
| Brain Metastases and Treatment | Lifetime | 83 | US 58 | 99.20 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 573 | US 277 | 98.49 |
| Neuroblastoma Research and Treatments | Lifetime | 310 | US 157 | 98.22 |
| Chromatin Remodeling and Cancer | Lifetime | 70 | US 37 | 97.83 |
| Sarcoma Diagnosis and Treatment | Lifetime | 578 | US 292 | 97.84 |
| Soft tissue tumor case studies | Lifetime | 192 | US 105 | 97.37 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 325 | US 185 | 97.73 |
| Vasculitis and related conditions | Lifetime | 309 | US 86 | 97.06 |
| Pituitary Gland Disorders and Treatments | Lifetime | 699 | US 264 | 96.70 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 364 | US 130 | 95.37 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 370 | US 174 | 95.71 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 830 | US 374 | 95.31 |
| Ocular Oncology and Treatments | Lifetime | 406 | US 217 | 94.45 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 934 | US 369 | 91.62 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 333 | US 83 | 91.67 |
| Hedgehog Signaling Pathway Studies | Lifetime | 993 | US 451 | 89.52 |
| Cerebrovascular and genetic disorders | Lifetime | 804 | US 210 | 77.76 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 14 | US 11 | 98.16 |
| Meningioma and schwannoma management | 2021-2025 | 49 | US 28 | 98.14 |
| Glioma Diagnosis and Treatment | 2021-2025 | 205 | US 86 | 97.91 |
| Chromatin Remodeling and Cancer | 2021-2025 | 19 | US 7 | 94.39 |
| Neuroblastoma Research and Treatments | 2021-2025 | 348 | US 135 | 90.89 |
| Pituitary Gland Disorders and Treatments | 2021-2025 | 444 | US 98 | 90.78 |
| Brain Metastases and Treatment | 2021-2025 | 544 | US 248 | 88.24 |
| Testicular diseases and treatments | 2021-2025 | 452 | US 115 | 72.98 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 483 | US 136 | 61.80 |
| Soft tissue tumor case studies | 2021-2025 | 566 | US 186 | 58.56 |